KYNAPID, created in 2007 (United States), from 67 sister brands and 17479 competing brands. The KYNAPID brand is owned by Astellas Pharma, a company listed in Francfort. The International Securities Identification Number (ISIN) of Astellas Pharma is JP3942400007. KYNAPID is part of the Drug Manufacturers activity sector.

KYNAPID is a brand of Astellas Pharma (YPH) Sustainability

International deposit : 2007 Business sector Drug Manufacturers
Here is the evolution of interest in Astellas Pharma "sustainability" criteria around the world over the past five years. The graph shows the evolution of the search rate over time, where the value 100 indicates the week with the most searches.
What is the brand's web response on its sustainability
Result of Google's query: "KYNAPID sustainability"
Sustainability -> Share price